AP6-backed Gyros to merge with Ampersand Capital's Protein Tech

Gyros AB, a Swedish developer of immunoassays agreed to merge with Tuscon, Arizona-based Protein Technologies Inc, a provider peptide synthesis tools, to form Gyros Protein Technologies AB. Swedish state-controlled pension fund AP6 and Ampersand Capital Partners, which own a majority of Gyros and Protein Tech, respectively, will become the major shareholders in the new company.

16 March 2016•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles